Indian Market Structure Report
Executive Summary
June 2026 saw Stage 2 structures expanded to 18.5% of the market (up +1.0pp), with 78 distinct companies recording new Stage 2 breakouts during the month.
Internal momentum was mixed, with 40.6% of companies exhibiting positive absolute strength and leadership breadth expanding to 9.8%.
Despite pockets of sectoral variation, sector stress was elevated, warranting closer monitoring of structural deterioration signals.
Market Structure
Stage Distribution
| Stage | Value |
|---|---|
| Stage 1 | 41% |
| Stage 2 | 18.5% |
| Stage 3 | 0.1% |
| Stage 4 | 40.4% |
Structural Leadership
Stage 4 declines (40.4%) substantially exceeded Stage 2 advancing structures (18.5%), indicating a structurally defensive market environment requiring elevated monitoring.
Market Participation
| Metric | Value |
|---|---|
| Positive Breadth | 40.6% |
| Leadership Breadth | 9.8% |
| Average Momentum | Moderate (+0.02σ) |
| Leadership Expansion | -3 |
Internal participation was moderate, with slightly positive momentum (z-score: +0.02σ) and leadership breadth at 9.8%.
Systemic Risk
| Metric | Value |
|---|---|
| Risk Density | 16.4 |
| Sector Stress | Elevated |
| Risk Environment | Cautionary |
Risk density of 16.40 signals elevated structural stress. Multi-sector deterioration patterns should be actively monitored.
Monthly Evolution
Flagium Interpretation
The Indian equity market exhibited a defensive structural posture in June 2026. Although Stage 4 declines continued to dominate the market landscape, several internal indicators showed modest stabilization.
Stage 4 structures declined from 49.9% to 40.4%, while leadership breadth expanding to 9.8% and new Stage 2 formations continued to emerge. Despite these improvements, the overall structural profile remained defensive, supporting a cautious capital allocation environment.
Historical observations of structural regimes do not guarantee future market outcomes. This report reflects the state of market internals at month-end and is not investment advice.